Amulet Pharmaceuticals
closedAmulet Pharmaceuticals discovers and develops novel therapeutics to address known liabilities of current therapies serving unmet markets.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD9—14m (Dealroom.co estimates Mar 2007.)
Rockville Maryland (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$1.7m | Series A | ||
| Total Funding | CAD2.3m | ||
Recent News about Amulet Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.